Avalon GloboCare Corp..
ALBT.US | Research and experimental development on natural sciences and engineering
Avalon GloboCare Corp. is a biotechnology company focused on developing and commercializing innovative immune-oncology therapies and exosome-based technologies. The company's core technology platforms include CAR-T cell therapy, Allo-CAR-T cell therapy, and functionalized exosome (ExoCarta) technolo...Show More
Better Health for All
20
Avalon GloboCare's core business involves developing immune-oncology therapies and exosome-based technologies, alongside precision diagnostics and clinical laboratory services, all aimed at improving patient outcomes.
1
The company launched the KetoAir™ breathalyzer, an FDA-registered Class I medical device, which measures ketosis and provides personalized health recommendations via an app.
2
This device is utilized in partnerships for weight management and wellness programs, with pilot participants reporting significant weight loss success.
3
No products with negative health impacts are mentioned, and no safety incidents, recalls, or adverse events have been reported for the FDA-registered device.
4
The KetoAir device and its associated programs emphasize disease prevention and health promotion through diet and exercise management. While the app collects diet and exercise data, there is no information regarding the company's health data protection policies or privacy safeguards.
Fair Money & Economic Opportunity
0
Avalon GloboCare Corp. is a biotechnology company focused on developing immune-oncology therapies, exosome-based technologies, and marketing medical devices like the KetoAir breathalyzer.
1
The company's core business activities do not involve lending, insuring, moving, or storing money for consumers. Consequently, the provided articles, which detail mergers, stock performance, financial filings, and product development, do not contain any relevant evidence to assess the company against the KPIs for 'Fair Money & Economic Opportunity'. These KPIs are specifically designed for financial institutions and their impact on consumer financial well-being. Therefore, all KPIs are omitted due to a lack of applicable data.
Fair Pay & Worker Respect
0
No quantitative data or specific evidence regarding fair pay and worker respect metrics, such as living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rates, pay equity, worker engagement, turnover rates, labor violation incidents, insecure contract share, or health insurance coverage, was found in the provided articles.
1
The available documents are policy-based (Code of Ethics) or biographical, and do not report on company performance against these metrics.
2
Fair Trade & Ethical Sourcing
0
No evidence available to assess Avalon GloboCare Corp. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, concrete evidence was found in the provided articles for any of the KPIs related to Honest & Fair Business. The articles indicate the presence of corporate governance documents but do not provide any quantitative data, regulatory actions, certifications, or other specific facts required to score the company against the rubric's metrics.
1
Kind to Animals
-60
Avalon GloboCare utilizes cell-based technologies for some pre-clinical research, such as tumor cytotoxicity studies for AVA-011.
1
However, animal models are also employed in preclinical studies to assess the efficacy of CAR T-cell therapies, and the AVA-Trap™ therapeutic program is currently entering animal model testing.
2
No explicit animal testing policy is stated, and the initiation of animal model testing for new programs suggests a lack of a robust policy against non-essential testing.
3
The company's GMP facility has a capacity of 16,000 square feet, with five bio-production lines for autologous cell therapy products (5,000 unit-doses/year capacity) and two for allogeneic cell therapy products (10,000 unit-doses/year capacity), indicating a significant scale of operations where animal testing is a component.
4
Avalon has collaborated with Arbele Limited, the University of Pittsburgh Medical Center, Massachusetts Institute of Technology (MIT), and the University of Natural Resources and Life Sciences (BOKU) on various therapeutic platforms.
5
No War, No Weapons
0
No specific, concrete data points were found in the provided articles to assess Avalon GloboCare Corp. against the 'No War, No Weapons' ethical value. The articles do not contain information regarding revenue from arms contracts, dual-use technologies, sales to embargoed regimes, peacebuilding investments, or any other military or conflict-related activities or policies.
1
The company's core business, as described, is biotechnology, and the articles do not link its operations or products to military or defense sectors.
2
Planet-Friendly Business
0
Avalon GloboCare Corp. has no material greenhouse gas emissions footprint, no carbon-emitting operations to target, and negligible or outsourced energy usage.
1
Its water usage, waste streams, capital expenditure, product lifecycle impacts, and material sourcing are not applicable or material to its operations.
2
The company also has no emissions to offset, no climate initiatives needed, and its supply chain climate impact is not material.
3
Furthermore, its operations do not affect biodiversity, are not connected to forest risk commodities, and do not require environmental impact assessments.
4
The company has no net-zero commitment required, and climate risk disclosure, climate scenario analysis, and stranded asset risks are not applicable.
5
Water sourcing, packaging operations, climate justice implications, workforce or communities affected by low-carbon transition, and climate adaptation needs are also not material to the business model.
6
No environmental compliance violations were reported.
7
Respect for Cultures & Communities
0
No incidents of cultural appropriation are mentioned in the provided articles.
1
No specific, concrete evidence was found for any other KPI related to 'Respect for Cultures & Communities', leading to their omission from the assessment.
Safe & Smart Tech
0
Avalon GloboCare Corp. (ALBT.US) reported no material cyber incidents or immaterial incidents requiring disclosure.
1
Furthermore, the company reported no incidents of unauthorized data use.
2
Zero Waste & Sustainable Products
0
No information was found regarding Avalon GloboCare Corp.'s waste diversion rate, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certifications, waste disposal violations, material efficiency, packaging to product ratio, waste reduction targets, supplier waste requirements, or customer waste education programs.
1